These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 12182459

  • 1. Novel assays of multiple lymphocyte functions in whole blood measure: new mechanisms of action of mycophenolate mofetil in vivo.
    Barten MJ, van Gelder T, Gummert JF, Shorthouse R, Morris RE.
    Transpl Immunol; 2002 Jun; 10(1):1-14. PubMed ID: 12182459
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pharmacodynamics of mycophenolate mofetil after heart transplantation: new mechanisms of action and correlations with histologic severity of graft rejection.
    Barten MJ, van Gelder T, Gummert JF, Boeke K, Shorthouse R, Billingham ME, Morris RE.
    Am J Transplant; 2002 Sep; 2(8):719-32. PubMed ID: 12243493
    [Abstract] [Full Text] [Related]

  • 4. Sustained suppression of peripheral blood immune functions by treatment with mycophenolate mofetil correlates with reduced severity of cardiac allograft rejection.
    Klupp J, van Gelder T, Dambrin C, Regieli JJ, Boeke K, Billingham ME, Morris RE.
    J Heart Lung Transplant; 2004 Mar; 23(3):334-51. PubMed ID: 15019644
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pharmacodynamics of mycophenolic acid in heart allograft recipients: correlation of lymphocyte proliferation and activation with pharmacokinetics and graft histology.
    Gummert JF, Barten MJ, van Gelder T, Billingham ME, Morris RE.
    Transplantation; 2000 Oct 15; 70(7):1038-49. PubMed ID: 11045640
    [Abstract] [Full Text] [Related]

  • 8. Individualizing combination of two antiproliferative immunosuppressants with pharmacodynamic modeling of stimulated lymphocyte responses.
    Berry V, Magill A, Yost M, Janosky J, Sindhi R.
    Cytometry A; 2006 Feb 15; 69(2):95-103. PubMed ID: 16369935
    [Abstract] [Full Text] [Related]

  • 9. Ex vivo lymphocyte proliferative function is severely inhibited in renal transplant patients on mycophenolate mofetil treatment.
    Hutchinson P, Jose M, Atkins RC, Holdsworth SR.
    Transpl Immunol; 2004 Feb 15; 13(1):55-61. PubMed ID: 15203129
    [Abstract] [Full Text] [Related]

  • 10. Assessment of immunosuppressive drug interactions: inhibition of lymphocyte function in peripheral human blood.
    Barten MJ, Dhein S, Chang H, Bittner HB, Tarnok A, Rahmel A, Mohr FW, Gummert JF.
    J Immunol Methods; 2003 Dec 15; 283(1-2):99-114. PubMed ID: 14659903
    [Abstract] [Full Text] [Related]

  • 11. Effects of mycophenolate mofetil on key pattern of coronary restenosis: a cascade of in vitro and ex vivo models.
    Voisard R, Viola S, Kaspar V, Weber CM, von Müller L, Baur R, Gastrock-Balitsch I, Hombach V.
    BMC Cardiovasc Disord; 2005 May 12; 5(1):9. PubMed ID: 15890069
    [Abstract] [Full Text] [Related]

  • 12. Down-regulation of multiple low dose streptozotocin-induced diabetes by mycophenolate mofetil.
    Maksimovic-Ivanic D, Trajkovic V, Miljkovic DJ, Mostarica Stojkovic M, Stosic-Grujicic S.
    Clin Exp Immunol; 2002 Aug 12; 129(2):214-23. PubMed ID: 12165076
    [Abstract] [Full Text] [Related]

  • 13. C0h/C2h monitoring of the pharmacodynamics of cyclosporin plus mycophenolate mofetil in human heart transplant recipients.
    Barten MJ, Rahmel A, Garbade J, Richter M, Bittner HB, Dhein S, Mohr FW, Gummert JF.
    Transplant Proc; 2005 Mar 12; 37(2):1360-1. PubMed ID: 15848720
    [Abstract] [Full Text] [Related]

  • 14. Comparison of the effects of tacrolimus and cyclosporine on the pharmacokinetics of mycophenolic acid.
    van Gelder T, Klupp J, Barten MJ, Christians U, Morris RE.
    Ther Drug Monit; 2001 Apr 12; 23(2):119-28. PubMed ID: 11294511
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics and dynamics of mycophenolate mofetil after single-dose oral administration in juvenile dachshunds.
    Grobman M, Boothe DM, Rindt H, Williamson BG, Katz ML, Coates JR, Reinero CR.
    J Vet Pharmacol Ther; 2017 Dec 12; 40(6):e1-e10. PubMed ID: 28649788
    [Abstract] [Full Text] [Related]

  • 16. Mycophenolic acid and 6-mercaptopurine both inhibit B-cell proliferation in granulomatosis with polyangiitis patients, whereas only mycophenolic acid inhibits B-cell IL-6 production.
    von Borstel A, Abdulahad WH, Dekkema G, Rutgers A, Stegeman CA, Veldman J, Heeringa P, Sanders JS.
    PLoS One; 2020 Dec 12; 15(7):e0235743. PubMed ID: 32645052
    [Abstract] [Full Text] [Related]

  • 17. Mycophenolate mofetil inhibits rat and human mesangial cell proliferation by guanosine depletion.
    Hauser IA, Renders L, Radeke HH, Sterzel RB, Goppelt-Struebe M.
    Nephrol Dial Transplant; 1999 Jan 12; 14(1):58-63. PubMed ID: 10052478
    [Abstract] [Full Text] [Related]

  • 18. Long-term changes in mycophenolic acid exposure in combination with tacrolimus and corticosteroids are dose dependent and not reflected by trough plasma concentration: a prospective study in 100 de novo renal allograft recipients.
    Kuypers DR, Claes K, Evenepoel P, Maes B, Coosemans W, Pirenne J, Vanrenterghem Y.
    J Clin Pharmacol; 2003 Aug 12; 43(8):866-80. PubMed ID: 12953344
    [Abstract] [Full Text] [Related]

  • 19. Effect of mycophenolate mofetil on rat kidney grafts with prolonged cold preservation.
    Fuller TF, Hoff U, Rose F, Linde Y, Freise CE, Dragun D, Feng S.
    Kidney Int; 2006 Aug 12; 70(3):570-7. PubMed ID: 16788694
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.